CIRM Funded Clinical Trials
Phase 1b Study of TN-401 in Adults with PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Disease Area:
Heart failure
Trial Sponsor:
Tenaya Therapeutics, Inc.
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
